Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial

PURPOSE: Diabetic peripheral neuropathic pain (DPNP) is one of the most sufferings, disabling, and dominant complications of diabetes. Duloxetine (DLX) and Pregabalin (PGB) are among first-line therapy and the most prescribed drugs for DPNP relief. The effectiveness-risk profile of drugs may differ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Diabetes Metab Disord
Asıl Yazarlar: Joharchi, Khojasteh, Memari, Moosareza, Azargashb, Eznollah, Saadat, Navid
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6915178/
https://ncbi.nlm.nih.gov/pubmed/31890684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40200-019-00427-w
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller